Study on the anticonvulsant activity of thymoquinone, the major constituent of Nigella sativa L. seeds, through intracerebroventricular injection

Journal of Medicinal Plants

Volumn 4, Issue 14, 2005, Pages 45-52

  Parvardeh, S ^b   Nassiri Asl, M ^b   Mansouri, M T ^b   Hosseinzadeh, H ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Biotechnology Section   (Iran)

Author keywords

Anticonvulsant; Nigella sativa; Pentylenetetrazole; Stereotaxy; Thymoquinone

Indexed keywords

FLUMAZENIL; NALOXONE; PENTETRAZOLE; THYMOQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; GABAERGIC SYSTEM; NONHUMAN; PLANT SEED; RAT; SEIZURE; TONIC CLONIC SEIZURE;

ANIMALIA; NIGELLA SATIVA;

EID: 23644444586     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mahfouz M, Abdel-Meguid R, El-Dakhakimy M. Effectiveness of 'Nigella' in Asthma. Alexandria Med. J. 1960; 6: 543-47.
2. Riaz M, Syed M, Chaudhary FM. Chemistry of the medicinal plants of the genus Nigella. Hamdard Medicus 1996; 39: 40-5.
3. Aqel-Mahmoud B. The relaxing effects of the volatile oil of Nigella sativa seeds on vascular smooth muscle. Dirasat Series B Pure Appl. Sci. 1993; 19: 91-100.
4. El-Tahir KEH, Al-Tahir AY, Ageel AM. Pharmacological studies on sesame and Nigella sativa fixed oil: Effects on the sensitivities of the adrenoceptors, baroreceprors, platelets and the uterus of the rat. Saudi Pharmac. J. 1999; 7: 205-15.
5. El-Tahir KEH, Ashour MMS, Al-Harbi MM. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: Elucidation of the mechanism of action. Gen. Pharmacol. 1993; 24: 1123-31.
6. Zaoui A, Cherrah Y, Lacaille-Dubois MA. Diuretic and hypotensive effects of Nigella sativa on the spontaneously hypertensive rat. Therapie 2000; 55: 379-82.
7. Aqel-Mahmoud B. Effects of Nigella sativa seeds on intestinal smooth muscle. Int. J. Pharmacol. 1993; 31: 55-60.
8. Gilani AH, Aziz N, Khurram IM. Bronchodilator, Spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J. Pak. Med. Assoc. 2001; 51: 115-20.
9. Aqel-Mahmoud B. The calcium antagonistic effect of the volatile oil of Nigella sativa seeds. Dirasat Series B Pure Appl. Sci. 1993; 19: 119-33.
10. Boskabadi MH, Shahabi M. Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Ir. J. Med. Sci. 1997; 22: 127-33.
11. Aqel M, Shaheen R. Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharmacol. 1996; 52: 23-6.
12. Ali BH, Blunden G. Pharmacological and Toxicological Properties of Nigella sativa. Phytother. Res. 2003; 17: 299-305.
13. Khanna T, Zaidi FA, Dandiya PC. CNS and analgesic studies on Nigella sativa. Fitoterapia 1993; 64: 407-10.
14. D'Antuono LF, Moretti A, Lovato FSA. Seed yield, yield components, oil content and essential oil content and composition of Nigella sativa L. and Nigella damascena L. Indust. Crops. Prod. 2002; 15: 59-69.
15. Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the Black seed (Nigella sativa L.). J. Pharm. Biomed. Anal. 1999; 19: 757-62.
16. Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004; 11: 56-64.
17. Paxions G, Watson C. The Rat Brain. Academic Press, San Diego, p: 22.
18. Brogden RN, Goa KL. Flumazenil: a preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs 1988; 35: 448-67.
19. Abdel-Fattah AFM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigeflla sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol 2000; 400: 89-97.
20. Yajima Y, Naritaa M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T. Effects of differential modulation of μ-, δ- and κ-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res. 2000; 862: 120-26.
21. Werz RL, Macdonald MA. Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons. Neuropept. 1984; 5: 253-6.
22. Werz MA, Macdonald RL. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J. Pharmacol. Exp. Ther. 1985; 234: 49-56.